The management team behind Azure Pharmaceuticals have decades of experience in the European medicines market and were to the fore in bringing generics to the market in Ireland; they were later instrumental to the significant growth of the generic medicine usage. This now stands at almost 60% of all medicines consumed in the Irish market.
With such strong credentials, Azure is now seeking to bring this entrepreneurial and commercial drive to this latest venture to create a new dynamic in the Irish medicines market.
Sandra Gannon, Managing Director was former General Manager for Teva in Ireland and Malta, where she led the company to becomes the largest supplier of medicines to Irish patients. She was Chair of the generics and biosimilars Healthcare Enterprise Alliance (HEA) and subsequently of the newly formed Medicines for Ireland.
Aideen Kenny was formerly Head of Commercial Operations in Teva Ireland and Malta and has extensive experience working in the branded (originator), generic and over-the-counter medicines markets. A qualified pharmacist, Aideen has a wealth of knowledge of the quality, regulatory an compliance requirements of the EU pharmaceutical market, as well as a proven track-record in commercial management.